Elation Health stands out as the premier platform for primary care, enabling 32,000 healthcare providers to offer tailored care to more than 16 million patients. By utilizing a clinically-focused electronic health record system, along with integrated billing solutions and AI-driven tools, Elation enhances care processes, ensuring that independent practices can flourish in a competitive landscape. This commitment to innovation not only improves patient outcomes but also streamlines operations for practitioners.
Learn more

An API driven by Google's AI capabilities enables precise transformation of spoken language into written text. This technology enhances your content with accurate captions, improves the user experience through voice-activated features, and provides valuable analysis of customer interactions that can lead to better service. Utilizing cutting-edge algorithms from Google's deep learning neural networks, this automatic speech recognition (ASR) system stands out as one of the most sophisticated available. The Speech-to-Text service supports a variety of applications, allowing for the creation, management, and customization of tailored resources. You have the flexibility to implement speech recognition solutions wherever needed, whether in the cloud via the API or on-premises with Speech-to-Text O-Prem. Additionally, it offers the ability to customize the recognition process to accommodate industry-specific jargon or uncommon vocabulary. The system also automates the conversion of spoken figures into addresses, years, and currencies. With an intuitive user interface, experimenting with your speech audio becomes a seamless process, opening up new possibilities for innovation and efficiency. This robust tool invites users to explore its capabilities and integrate them into their projects with ease.
Learn more
Illumina DRAGEN Secondary Analysis
The DRAGEN Secondary Analysis system from Illumina provides accurate, comprehensive, and exceptionally efficient processing of next-generation sequencing data. By leveraging a graph reference genome in combination with machine learning methodologies, it achieves outstanding precision. With a highly streamlined workflow, it can fully analyze a 34x whole human genome in roughly 30 minutes when operated on the DRAGEN server v4. Furthermore, it optimizes this process by reducing FASTQ file sizes by as much as five times. This system is proficient in handling diverse types of NGS data, such as whole genomes, exomes, methylomes, and transcriptomes. It has been designed to work seamlessly with the user's chosen platform and can scale to accommodate various needs. DRAGEN analysis is consistently recognized as a frontrunner in accuracy for detecting both germline and somatic variants, supported by its strong performance in industry competitions hosted by precisionFDA. This sophisticated analytical tool enables laboratories of all sizes and specialties to fully leverage their genomic datasets. Additionally, the integration of highly adaptable field-programmable gate array (FPGA) technology allows DRAGEN to implement hardware-accelerated genomic analysis algorithms, significantly improving its efficiency. These advancements firmly establish DRAGEN as an essential asset in the rapidly advancing realm of genomics, enabling researchers to push the boundaries of scientific discovery.
Learn more
VSClinical
VSClinical enhances the clinical evaluation of genetic variants by aligning with the guidelines set forth by the ACMG and AMP. Its organized workflow ensures compliance with the standards established by the American College of Medical Genetics (ACMG), which are crucial for identifying and classifying pathogenic variants associated with inherited diseases, cancer risk, and rare diagnoses. The integrated ACMG/AMP guidelines for variant interpretation provide a systematic approach for scoring variants and placing them into one of five classification categories. To effectively implement these guidelines, a comprehensive analysis of annotations, genomic contexts, and existing clinical data for each variant is required. VSClinical simplifies this task by delivering a tailored workflow that assesses each pertinent criterion while offering extensive bioinformatics resources, literary references, and insights from clinical databases to support the scoring and interpretation process. This forward-thinking method aims to improve the productivity of variant scientists as they manage the intricacies of variant analysis and processing. Ultimately, VSClinical emerges as a crucial resource for expediting the understanding and classification of genetic variants within clinical environments, fostering better patient outcomes through informed decision-making. Its role in facilitating efficient variant analysis cannot be overstated, as it significantly contributes to the advancement of personalized medicine.
Learn more